Cytomegalovirus vaccine (Triplex, Helocyte)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameCytomegalovirus vaccine (Triplex, Helocyte)
Drug Alias Name巨细胞病毒疫苗 - Triplex, HelocyteMulti-CMV epitope modified vaccinia Ankara vaccineCMV-MVA TriplexCMV-MVA Triplex VaccineMulti-peptide CMV-Modified Vaccinia Ankara Vaccine (Triplex, Helocyte) +[6] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBone marrow transplant rejectionLymphadenopathyPrimary Myelofibrosis +[21] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesDiavax BiosciencesMasonic Cancer Center, University Of MinnesotaCity Of Hope National Medical Center +[4] 
Inactive CompaniesN/A
Active IndicationsLymphadenopathyPrimary MyelofibrosisMyeloproliferative Disorders +[20] 
Inactive IndicationsBone marrow transplant rejection

Other Information

ATC CodeN/A
Related LinksN/A